Skip to content
HowShorted

Humacyte, Inc. short interest in 2026

In 2026, Humacyte, Inc.'s disclosed short interest ran from 19.84% of shares outstanding on 15 Jan 2026 to 11.45% on 15 Sep 2026, a change of -8.39 percentage points. The year's high was 21.72% on 13 Mar 2026 and its low 10.73% on 31 Aug 2026, averaging 17.22% across 17 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 10.36 days on 13 Mar 2026. Full history: Humacyte, Inc..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for Humacyte, Inc. in 2026

2026 in figures

Start of year
19.84% (15 Jan 2026)
End of year
11.45% (15 Sep 2026)
Change
-8.39 pp
High
21.72% (13 Mar 2026)
Low
10.73% (31 Aug 2026)
Average
17.22%
Highest days to cover
10.36 (13 Mar 2026)
SEC filings marked
5

Every report in 2026

Humacyte, Inc. short interest in 2026
SettlementShort interestDays to coverFilings since previous
15 Jan 202619.84%7.58
30 Jan 202620.74%8.05
13 Feb 202620.93%5.22
27 Feb 202620.38%8.88
13 Mar 202621.72%10.36
31 Mar 202619.02%3.03results (8-K), 10-K filed
15 Apr 202620.20%9.40
30 Apr 202620.13%10.01
15 May 202618.54%5.1910-Q filed
29 May 202618.08%6.14
15 Jun 202616.53%4.10
30 Jun 202614.23%1.25
15 Jul 202614.54%3.34
31 Jul 202614.18%6.92
14 Aug 202611.50%3.3610-Q filed, results (8-K)
31 Aug 202610.73%3.40
15 Sep 202611.45%7.25

See also: Humacyte, Inc.'s full history · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.